Erudio Healtherudio.com
Indication
Diffuse large B-cell lymphoma
1 HCP commentary report on clinical trials in Diffuse large B-cell lymphoma. Each report covers what clinicians said in public about one trial, with the source behind every view.
| Trial | Indication | Phase | Statements | HCP sources | Size | Updated | Preview |
|---|---|---|---|---|---|---|---|
| EPCORE DLBCL-1 NCT04628494 · Genmab | relapsed/refractory diffuse large B-cell lymphoma | Phase 3 | 113 | 19 | Focused | Oct 31, 2026 | Preview |